17 Self-efficacy is an individual’s confidence or belief in his own capability of performing an action, and is a salient predictor of health behavior change and maintenance.18 Self-efficacy is a key factor because it operates based on motivation and action both directly and through its impact on the other determinants.19 Studies adopting the TPB for physical activity

behavior have catalogued the independent influence of self-efficacy Inhibitors,research,lifescience,medical on intention and behavior.20 Moreover, a number of studies successfully paired self-efficacy with the TPB in various behavioral settings.21,22 Self-efficacy is more concerned with cognitive AZD-2281 perceptions of the control Inhibitors,research,lifescience,medical based on internal control factors. Further, in a comparison of the theories of reasoned action, planned behavior and social cognitive theory, self-efficacy rather than Perceived behavioral control (PBC), had a direct impact on behavior.23 Previous studies have highlighted the distinction between the TPB and self efficacy. Consequently, this current study used an expanded TBP model which incorporates the two constructs of attitude, subjective norm

and PBC as well as self-efficacy, to investigate Inhibitors,research,lifescience,medical physical activity intention and behavior in elderly men. Aims of the Study This study aims to identify the relationship of the TPB and self-efficacy constructs associated with self-reported physical activity behavior and physical activity intention in elder Inhibitors,research,lifescience,medical men. Lastly, we attempt to identify and compare the effectiveness of the TPB with self-efficacy as predictors of physical activity and intention. Materials and Methods Participants and Procedure The study was a cross-sectional study using a census sample

of 120 elder men Inhibitors,research,lifescience,medical aged 60 to 85 years in a population of elderly men, who constituted whole resident of Kahrizak nursing home in Tehran, Iran. The Institutional Review Board of the approved and supported the study. After institutional ethical approval, the investigators were introduced to Kahrizak nursing home by research administration of . The objectives and methodology of the study was explained to the management of Kahrizak Brefeldin_A Nursing Home, and its approval was obtained. The sample size, calculated using an α of 0.05 and a power of 0.95, was found to be 120 individuals. Therefore, 120 old men kinase inhibitor Brefeldin A possessing the inclusion criteria were selected. The inclusion criteria for the study were an age of 60 years or older, independent living (no assistance from paid or unpaid persons for personal care), no suffering from several diseases including osteoarthritis, heart diseases, osteoporosis, pulmonary diseases, and ability for independent mobility (moving without canes, etc.), and ability of verbal communication.